J Scott Beeler

9PUBLICATIONS
62CO-AUTHORS
Haematological tumoursPacific Peoples midwifery and paediatricsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 10, 2026
Pivekimab sunirine and the evolving treatment of blastic plasmacytoid dendritic cell neoplasm.

|Sep 28, 2026
Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment.

|Mar 12, 2026
CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis.

Irenaeus C C Chan, Pu Zhang, Xiangyu Pan

|Mar 06, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.

Duc Tran, J Scott Beeler, Jie Liu

|Jul 28, 2021
Tissue-specific expression of p73 and p63 isoforms in human tissues.

Clayton B Marshall, J Scott Beeler, Brian D Lehmann

|Mar 13, 2020
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors.

Johanna M Schafer, Brian D Lehmann, Paula I Gonzalez-Ericsson

Pageof 2

Frequent Collaborators

4 joint publications

Kelly L Bolton

4 joint publications

Giulia Petrone

4 joint publications

Duc Tran

3 joint publications

Armel L Batchi-Bouyou